Eiken Chemical Co (TSE:4549) EBIT : 円3,884 Mil (TTM As of Dec. 2023)

View and export this data going back to 1990. Start your Free Trial

What is Eiken Chemical Co EBIT?

Eiken Chemical Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was 円1,264 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was 円3,884 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Eiken Chemical Co's annualized ROC % for the quarter that ended in Dec. 2023 was 8.96%. Eiken Chemical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 18.29%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Eiken Chemical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.53%.

Eiken Chemical Co EBIT Historical Data

The historical data trend for Eiken Chemical Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eiken Chemical Co EBIT Chart

Eiken Chemical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT

Get a 7-Day Free Trial

4,656.00

4,728.00

6,872.00

8,489.00

7,608.00

Eiken Chemical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															1,391.00	440.00	1,041.00	1,139.00	1,264.00

Competitive Comparison of Eiken Chemical Co's EBIT

For the Medical Devices subindustry, Eiken Chemical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eiken Chemical Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eiken Chemical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Eiken Chemical Co's EV-to-EBIT falls into.

Eiken Chemical Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,884 Mil.

Eiken Chemical Co (TSE:4549) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Eiken Chemical Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	5076 * ( 1 - 24.37% )	/	( (42753	+	42934)	/ 2 )
=	3838.9788	/	42843.5
=	8.96 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	66765	-	5138	-	( 18874	-	max(0, 12126	-	40920	+	18874	))
=	42753

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	65195	-	4535	-	( 17726	-	max(0, 10603	-	39674	+	17726	))
=	42934

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Eiken Chemical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	5056	/	( ( (17115 + max(9920, 0))	+	(16912 + max(11345, 0)) )	/	2 )
=	5056	/	( ( 27035	+	28257 )	/	2 )
=	5056	/	27646
=	18.29 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(12673	+	8392	+	981)	-	(5138	+	0	+	6988)
=	9920

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(12620	+	8441	+	887)	-	(4535	+	0	+	6068)
=	11345

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Eiken Chemical Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	3884	/	59521.158
	=	6.53 %

Eiken Chemical Co EBIT Related Terms

Thank you for viewing the detailed overview of Eiken Chemical Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Eiken Chemical Co (TSE:4549) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eiken Chemical Co Ltd (TSE:4549) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-19-9 Taito, Taito-ku, Tokyo, JPN, 110-8408

Website

http://www.eiken.co.jp

Eiken Chemical Co Ltd is a Japan-based company. It manufactures and sells clinical diagnostics and equipment. The company is engaged in processing, manufacture, purchase and sale of test agents, property and casualty insurance agency business. It as a general manufacturer of clinical diagnostics offers a wide range of in vitro diagnostic aids for all fields of medicine. Its major products include the Fecal immunochemical test, Molecular Genetics (LAMP), Microbiology, among many others.

Eiken Chemical Co (TSE:4549) Headlines

No Headlines